Topics
News
CME/CE
Editorial Advisory Board
Partners
Subscribe
- General Dermatology
- Eczema
- Chronic Hand Eczema
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
- Prurigo Nodularis
Article
RESTYLANE STUDIED
Restylane, a new facial filler, may soon be FDA approved. In a study of 2,241 Brazilian patients conducted by Drs. Stephen Bosniak and Marian Cantisano-Zilkha between 1996 and 2001, patients who were treated with Restylane were found to have virtually no allergic reactions.
Related Videos
Related Content
